ACMSD and acute kidney injury: The use of the ACMSD inhibitor has proven to be efficient in protecting renal function in two different models of AKI: one induced by a single intraperitoneal (i.p.)application of cisplatin and the other induced by ischemia/reperfusion (I/R) induction achieved by clamping renal pedicles for 25 min.